Literature DB >> 10227805

GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels.

I A Ferber1, H J Lee, F Zonin, V Heath, A Mui, N Arai, A O'Garra.   

Abstract

IL-12 and IL-4 are dominant factors driving the development of Th1 and Th2 cells, respectively, by their activation of Stat-4 and Stat-6 signaling molecules. Activation of Stat factors, although specific, is a rapid event; however, differentiation of Th cells takes place over several days. Thus, it is unlikely that the expression of effector cytokines is mediated solely by Stat factors. Recently there have been indications that link other molecular factors to Th subset development. The transcription factor GATA-3 is selectively expressed in Th2 cells and has been shown to induce the expression of Th2 cytokines in developing Th1 cells. Using retroviral infection of naive T cells to introduce GATA-3 cDNA, we measured its direct effects on the development of Th1 cytokine production. We now show that ectopic expression of GATA-3 in developing Th1 cells significantly inhibits IFN-gamma, as well as enhancing IL-4 and IL-5 production. Furthermore, GATA-3 inhibits production of IFN-gamma by developing Th1 cells in the complete absence of IL-4. Thus, antagonism of Th1 development by GATA-3 may facilitate rapid divergence of Th subsets toward a Th2 phenotype in concert with other factors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227805     DOI: 10.1006/clim.1999.4718

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  33 in total

1.  Kinetics of GATA-3 gene expression in early polarizing and committed human T cells.

Authors:  E Lantelme; S Mantovani; B Palermo; R Campanelli; F Sallusto; C Giachino
Journal:  Immunology       Date:  2001-02       Impact factor: 7.397

Review 2.  T helper subset development: roles of instruction, selection, and transcription.

Authors:  J David Farrar; Helene Asnagli; Kenneth M Murphy
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

Review 3.  An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation.

Authors:  Ryoji Yagi; Jinfang Zhu; William E Paul
Journal:  Int Immunol       Date:  2011-06-01       Impact factor: 4.823

4.  GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model.

Authors:  Thomas Höfer; Holger Nathansen; Max Löhning; Andreas Radbruch; Reinhart Heinrich
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-26       Impact factor: 11.205

Review 5.  Helper T cell differentiation and the problem of cellular inheritance.

Authors:  Steven L Reiner; Alan C Mullen; Anne S Hutchins; Erika L Pearce
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

6.  Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease.

Authors:  Y Kakuta; Y Kinouchi; K Negoro; S Takahashi; T Shimosegawa
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

Review 7.  How diverse--CD4 effector T cells and their functions.

Authors:  Yisong Y Wan; Richard A Flavell
Journal:  J Mol Cell Biol       Date:  2009-05-28       Impact factor: 6.216

8.  Overexpression of the transcription factor GATA-3 enhances the development of pulmonary fibrosis.

Authors:  Toru Kimura; Yukio Ishii; Keigyou Yoh; Yuko Morishima; Takashi Iizuka; Takumi Kiwamoto; Yosuke Matsuno; Shinsuke Homma; Akihiro Nomura; Tohru Sakamoto; Satoru Takahashi; Kiyohisa Sekizawa
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 9.  'All things considered': transcriptional regulation of T helper type 2 cell differentiation from precursor to effector activation.

Authors:  Wei-ping Zeng
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

10.  DNA methylation and not allelic variation regulates STAT6 expression in human T cells.

Authors:  Eu-Gene Kim; Hyun-Jin Shin; Chang Geun Lee; Hye-Young Park; Yoon-Keun Kim; Heung-Woo Park; Sang-Heon Cho; Kyung-Up Min; Mi-La Cho; Sung-Hwan Park; Chang-Woo Lee
Journal:  Clin Exp Med       Date:  2009-12-01       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.